The preliminary results for Johnson & Johnson’s (J&J) late-stage Covid-19 vaccine trial should be available by January 21 and will then be submitted to the US Food and Drug Administration, according to the protocol chair for the local arm of the trial, Medical Research Council president Glenda Gray.

SA has a particularly keen interest in J&J’s shot because local pharmaceutical manufacturer Aspen Pharmacare secured a deal with the US-based firm in November that will see it fill and package as many as 300-million vials per year at its sterile plant in Port Elizabeth...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now